The free session covers nutrition, exercise, side effects and common myths for people curious about GLP-1 medications. A local event listing.
Recap by typeshit. Post by Facebook on Facebook.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
A brief post raises a possible link between GLP-1 medications and lower odds of age-related macular degeneration in people with diabetes. No study details given.
Christina DiArcangelo points out that GLP-1 drugs now come in different versions for weight loss and metabolic health, and argues they shouldn't be treated as interchangeable.
Loading…